In vivo experiments further demonstrated that FKA significantly reduces the number of PAS+/CD31- VM structures, thereby exerting its anti-VM effects in HCC (Xiao et al., 2023). This evidence concerns the gene PECAM1 and hepatocellular carcinoma.